{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:19:15Z","timestamp":1782785955251,"version":"3.54.5"},"reference-count":56,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>As a complication of systemic lupus erythematosus (SLE), the neuropsychiatric form may manifest with neurological and psychiatric symptoms. Diagnosing neuropsychiatric SLE can be challenging due to the heterogeneity of this disease manifestation and the possibilities of investigation. This research aims to identify the possible associations between inflammation and thrombotic biomarkers alongside anxiety and\/or depression manifestations in SLE patients. A group of 65 outpatients were investigated regarding the levels of depression, anxiety, disability, quality of life and other specific serum biomarkers linked with inflammation or coagulopathies. The results showed severe depression in eight participants, moderate depression in 22 (33.85%), and 26 (40%) subjects with mild depression. Anxiety was more prevalent within 64 participants (98.46%), while a degree of disability was reported by 52 participants (80%). Quality of life evaluated by EQ5D revealed a medium value of 1.57, and EQ5D VAS health medium value was 57.95 and was correlated with anxiety. A strong positive correlation between depression, anxiety and antibodies associated with anti-cardiolipin and anti beta2 glycoprotein I antibodies, lupus anticoagulant, ICAM-1, low C4 a and anti-ribosomal P antibodies were identified. These data results suggest that autoimmune\/inflammatory and ischemic\/thrombotic pathways could contribute to depression and anxiety as neuropsychiatric SLE manifestations.<\/jats:p>","DOI":"10.3390\/biom13030567","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T07:56:37Z","timestamp":1679298997000},"page":"567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between Inflammation and Thrombotic Pathway Link with Pathogenesis of Depression and Anxiety in SLE Patients"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3062-766X","authenticated-orcid":false,"given":"Liliana","family":"Duca","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Transilvania University of Bra\u015fov, 500036 Bra\u015fov, Romania"},{"name":"Department of Clinical Immunology, County Emergency Clinic Hospital, 500326 Bra\u015fov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-2589","authenticated-orcid":false,"given":"Nadinne","family":"Roman","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Transilvania University of Bra\u015fov, 500036 Bra\u015fov, Romania"},{"name":"Clinical Hospital of Psychiatry and Neurology of Brasov, 500123 Bra\u015fov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Teodorescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Transilvania University of Bra\u015fov, 500036 Bra\u015fov, Romania"},{"name":"Clinical Hospital of Psychiatry and Neurology of Brasov, 500123 Bra\u015fov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petru","family":"Ifteni","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Transilvania University of Bra\u015fov, 500036 Bra\u015fov, Romania"},{"name":"Clinical Hospital of Psychiatry and Neurology of Brasov, 500123 Bra\u015fov, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"998328","DOI":"10.3389\/fcell.2022.998328","article-title":"Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: A review","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/00325481.2018.1492309","article-title":"Diagnostic approach to neuropsychiatric lupus erythematosus: What should we do?","volume":"130","author":"Zardi","year":"2018","journal-title":"Postgrad. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic Manifestations of Systemic Lupus Erythematosus in Children and Adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kivity, S., Agmon-Levin, N., Zandman-Goddard, G., Chapman, J., and Shoenfeld, Y. (2015). Neuropsychiatric lupus: A mosaic of clinical presentations. BMC Med., 13.","DOI":"10.1186\/s12916-015-0269-8"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rdc.2009.12.007","article-title":"Glutamate Receptor Biology and its Clinical Significance in Neuropsychiatric Systemic Lupus Erythematosus","volume":"36","author":"Aranow","year":"2010","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semarthrit.2019.06.017","article-title":"Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis","volume":"50","author":"Moustafa","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_9","first-page":"665","article-title":"Subscale analysis of quality of life in patients with systemic lupus erythematosus: Association with depression, fatigue, disease activity and damage","volume":"30","author":"Choi","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_10","first-page":"1349042","article-title":"Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China","volume":"2021","author":"Zhang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: New mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: Identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"56","author":"Cohen","year":"2017","journal-title":"Rheumatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5387\/fms.2020-02","article-title":"Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: The quest for symptom-specific biomarkers","volume":"66","author":"Sato","year":"2020","journal-title":"Fukushima J. Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_15","first-page":"e17969","article-title":"Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges","volume":"13","author":"Sarwar","year":"2021","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2009.08.005","article-title":"Magnetic Resonance Imaging and Brain Histopathology in Neuropsychiatric Systemic Lupus Erythematosus","volume":"40","author":"Sibbitt","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","article-title":"Inflammatory markers in depression","volume":"22","author":"Dinan","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.immuni.2014.10.008","article-title":"Leukocyte Migration into Inflamed Tissues","volume":"41","author":"Nourshargh","year":"2014","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eabi4994","DOI":"10.1126\/scitranslmed.abi4994","article-title":"Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis","volume":"13","author":"Scherlinger","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5114\/reum.2022.115664","article-title":"Adhesion molecules: A way to understand lupus","volume":"60","author":"Nowak","year":"2022","journal-title":"Rheumatology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Andrianova, I.A., Khabirova, A.I., Ponomareva, A.A., Peshkova, A.D., Evtugina, N.G., Le Minh, G., Sibgatullin, T.B., Weisel, J.W., and Litvinov, R.I. (2022). Chronic Immune Platelet Activation Is Followed by Platelet Refractoriness and Impaired Contractility. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137336"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08820139.2019.1624769","article-title":"Elevated blood and urinary ICAM-1 is a biomarker for systemic lupus erythematosus: A systematic review and meta-analysis","volume":"49","author":"Cheng","year":"2020","journal-title":"Immunol. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0961203318819137","article-title":"Evaluation of coagulation disorders by thromboelastography in children with systemic lupus erythematosus","volume":"28","author":"Li","year":"2019","journal-title":"Lupus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","article-title":"Association of inflammation with depression and anxiety: Evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts","volume":"26","author":"Milaneschi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","article-title":"The intriguing relationship between coronary heart disease and mental disorders","volume":"20","author":"Detraux","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0036","DOI":"10.5041\/RMMJ.10170","article-title":"Coagulation and Mental Disorders","volume":"5","author":"Nardi","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.autrev.2005.01.008","article-title":"Neuropsychiatric features of syste-mic lupus erythematosus","volume":"4","author":"Borchers","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/096120301671577528","article-title":"Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: Association with the presence of seizures","volume":"10","author":"Shrivastava","year":"2001","journal-title":"Lupus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/14397595.2018.1508801","article-title":"Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric\/neuropsychological syn-dromes in systemic lupus erythematous involving a severe form of the disease","volume":"29","author":"Arinuma","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Duca, L., Roman, N.A., Miron, A., Teodorescu, A., Dima, L., and Ifteni, P. (2022). WHODAS Assessment Feasibility and Mental Health Impact on Functional Disability in Systemic Lupus Erythematosus. Healthcare, 10.","DOI":"10.3390\/healthcare10061053"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, S.L., Wu, B., Zhu, L.A., Leng, L., Bucala, R., and Lu, L.J. (2014). Construct and Criterion Validity of the Euro Qol-5D in Patients with Systemic Lupus Erythematosus. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098883"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Liao, J., Kang, J., Li, F., Li, Q., Wang, J., Tang, Q., Ni Mao, N., Li, S., and Xie, X. (2022). A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus. BMC Psychiatry, 22.","DOI":"10.1186\/s12888-022-04236-z"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6290736","DOI":"10.1155\/2022\/6290736","article-title":"Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus","volume":"2022","author":"Chalhoub","year":"2022","journal-title":"Int. J. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1080\/09638288.2018.1522550","article-title":"The contributions of socioeconomic status, perceived stress, and depression to disability in adults with systemic lupus erythematosus","volume":"42","author":"Sumner","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/JIR.S277373","article-title":"Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G\/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study","volume":"13","author":"Yousef","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41380-021-01264-1","article-title":"Mechanisms affecting brain remodeling in depression: Do all roads lead to impaired fibrinolysis?","volume":"27","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: Pathogenesis and biomarkers","volume":"10","author":"Muller","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3899\/jrheum.090778","article-title":"EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with Rheumatoid Arthritis, Noninflammatory Rheumatic Disorders, and Fibromyalgia","volume":"37","author":"Wolfe","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12955-021-01731-x","article-title":"The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings","volume":"19","author":"Short","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5166 patients and 5083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-0033-1357488","article-title":"Antiphospholipid Antibodies: Neuropsychiatric Presentations","volume":"39","author":"Gris","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2022-eular.2329","article-title":"ab0496 should antibodies to domain i b2-glycoprotein 1 be investigated in patients with antiphospholipid syndrome (aps) and systemic lupus erythematosus (SLE)?","volume":"81","author":"Cheldieva","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/09612033211014248","article-title":"Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset","volume":"30","author":"Elkhalifa","year":"2021","journal-title":"Lupus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/0961203320938453","article-title":"Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus","volume":"29","author":"Aso","year":"2020","journal-title":"Lupus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0961203316643170","article-title":"Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus","volume":"25","author":"Schaarenburg","year":"2016","journal-title":"Lupus"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/STROKEAHA.108.514687","article-title":"Platelet C4d Is Associated with Acute Ischemic Stroke and Stroke Severity","volume":"39","author":"Mehta","year":"2008","journal-title":"Stroke"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/ard.2008.090670","article-title":"Complement activation in patients with primary antiphospholipid syndrome","volume":"68","author":"Oku","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/1073191119887449","article-title":"Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale-21 (DASS-21) Across Eight Countries","volume":"28","author":"Zanon","year":"2021","journal-title":"Assessment"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2018.11.003","article-title":"Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-Gen","volume":"56","author":"Staples","year":"2019","journal-title":"Hosp. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/keaa379","article-title":"Classifying and diagnosing systemic lupus erythematosus in the 21st century","volume":"59","author":"Aringer","year":"2020","journal-title":"Rheumatology"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/3\/567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:59:32Z","timestamp":1760122772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/3\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["biom13030567"],"URL":"https:\/\/doi.org\/10.3390\/biom13030567","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}